Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release
– 9 Month Interim Analysis of Open-label Study to be Presented at a Major Scientific Conference…
– 9 Month Interim Analysis of Open-label Study to be Presented at a Major Scientific Conference…
New BlockhouseCH House will seek to Coordinate Top Creators and Experts to Drive Value in…
DENVER, April 21, 2021 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:…
Primary efficacy in the second interim analysis demonstrates COVAXIN to be 78% effective after the…
Loughborough, England, April 21, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or…
Summit Therapeutics Inc.(‘Summit’ or the ‘Company’) Summit Therapeutics Announces Commencement of Rights Offering Cambridge, MA,…
MONTREAL, April 21, 2021 (GLOBE NEWSWIRE) — ExCellThera Inc., a clinical-stage cell and molecular medicine…
Over 5000 Patients Enrolled in 20 countries EDMONTON, Alberta, April 21, 2021 (GLOBE NEWSWIRE) —…
CARLSBAD, Calif., April 21, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global…
Company’s specimen collection kit now available for use in COVID-19 testing in the U.S. Sample…